Seizures in the elderly: Nuances in presentation and treatment

Cleveland Clinic Journal of Medicine

Volumn 72, Issue SUPPL.3, 2004, Pages

  Waterhouse, Elizabeth ^a   Towne, Alan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

AGED; DIFFERENTIAL DIAGNOSIS; HUMAN; REVIEW; SEIZURE;

AGED; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; SEIZURES;

EID: 84884563785     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.Suppl_3.S26     Document Type: Article

References (84)

1. US Department of Health & Human Services, Administration on Aging. Older population by age: 1900 to 2050. Available at: http://www.aoa.dhhs.gov/prof/statistics/online_stat_data/popage205 0.xls. Accessed August 16, 2005.
2. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34:453-468.
3. Hauser WA. Epidemiology of seizures and epilepsy in the elderly. In: Rowan AJ, Ramsay RE, eds. Seizures and Epilepsy in the Elderly. Newton, MA: Butterworth-Heinemann; 1997:7-18.
4. Annegers JF, Hauser WA, Lee JR-J, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995; 36:327-333.
5. Loiseau J, Loiseau P, Duche B, Guyot M, Dartigues JF, Aublet B. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol 1990; 27:232-237.
6. Kilpatrick CJ, Davis SM, Hopper JL, Rossiter SC. Early seizures after acute stroke. Risk of late seizures. Arch Neurol 1992; 49:509-511.
7. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 1996; 46:350-355.
8. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001; 57:200-206.
9. Franson KL, Hay DP, Neppe V, et al. Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs Aging 1995; 7:38-48.
10. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000; 41:342-351.
11. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy-a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64:1868-1873.
12. Paradowski B, Zagrajek MM. Epilepsy in middle-aged and elderly people: a three-year observation. Epileptic Disord 2005; 7:91-95.
13. Hauser WA, Ramirez-Lassepas M, Rosenstein R. Risk for seizures and epilepsy following cerebrovascular insults [abstract]. Epilepsia 1984; 25:666.
14. Scheuer ML, Cohn J. Seizures and epilepsy in the elderly. Neurol Clin 1993; 11:787-804.
15. McAreavay M, Ballinger B. Epileptic seizures in elderly patients with dementia. Epilepsia 1992; 33:657-660.
16. Kramer G. Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects. Epilepsia 2001; 42(suppl 3):55-59.
17. Hauser WA. Seizure disorders: the changes with age. Epilepsia 1992; 33(suppl 4):S6-S14.
18. Swann JW, Smith KL, Brady RJ. Age-dependent alterations in the operations of hippocampal neural networks. Ann N Y Acad Sci 1991; 627:264-276.
19. Jensen FE, Holmes GL, Lombroso CT, Blume HK, Firkusny IR. Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia 1992; 33:971-980.
20. Rowley HL, Ellis Y, Davies JA. Age-related effects of NMDAstimulated concomitant release of nitric oxide and glutamate in cortical slices prepared from DBA/2 mice. Brain Res 1993; 613:49-53.
21. Holmes GL, Thurber SJ, Liu Z, Stafstrom CE, Gatt A, Mikati MA. Effects of quisqualic acid and glutamate on subsequent learning, emotionality, and seizure susceptibility in the immature and mature animal. Brain Res 1993; 623:325-328.
22. Tsuda H, Ito M, Oguro K, et al. Age- and seizure-related changes in noradrenaline and dopamine in several brain regions of epileptic El mice. Neurochem Res 1993; 18:111-117.
23. Dichter MA, Weinberger LM. Epileptogenesis and the aging brain. In: Rowan AJ, Ramsay RE, eds. Seizures and Epilepsy in the Elderly. Newton, MA: Butterworth-Heinemann; 1997:21-27.
24. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22:489-501.
25. Kellinghaus C, Loddenkemper T, Dinner DS, Lachhwani D, Luders HO. Seizure semiology in the elderly: a video analysis. Epilepsia 2004; 45:263-267.
26. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62(suppl 2):S24-S29.
27. Norris JW. Misdiagnosis of stroke. Lancet 1982; 1:328-331.
28. Spitz MC, Bainbridge JL, Ramsay RE, et al, and DVA CSP Study Group. Observations on the delay in the diagnosis of seizures in the elderly: update 2. Epilepsia 2002; 43(suppl 7):166. Abstract.
29. McBride AE, Shih TT, Hirsch LJ. Video-EEG monitoring in the elderly: a review of 94 patients. Epilepsia 2002; 43:165-169.
30. Sirven JI. Acute and chronic seizures in patients older than 60 years. Mayo Clin Proc 2001; 76:175-183.
31. Nei M, Ho RT. Transient loss of consciousness: syncope and seizure. In: Sirven JI, Malamut BL, eds. Clinical Neurology of the Older Adult. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:76-89.
32. Van Cott AC. Epilepsy and EEG in the elderly. Epilepsia 2002; 43(suppl 3):94-102.
33. Ajmone-Marsan C, Zivin LS. Factors related to the occurrence of typical paroxysmal abnormalities in the EEG records of epileptic patients. Epilepsia 1970; 11:361-381.
34. Ramsay RE, Pryor F. Epilepsy in the elderly. Neurology 2000; 55(suppl 1):S9-S14.
35. Drury I, Selwa LM, Schuh LA, et al. Value of inpatient diagnostic CCTV-EEG monitoring in the elderly. Epilepsia 1999; 40:1100-1102.
36. American Academy of Neurology. Practice parameter: Neuroimaging in the emergency patient presenting with seizure: summary statement. Quality Standards Subcommittee of the American Academy of Neurology in cooperation with American College of Emergency Physicians, American Association of Neurological Surgeons, and American Society of Neuroradiology. Neurology 1996; 47:288-291.
37. Hopkins A, Garman A, Clarke C. The first seizure in adult life. Value of clinical features, electroencephalography, and computerised tomographic scanning in prediction of seizure recurrence. Lancet 1988; 1:721-726.
38. Sperling MR, Bucurescu G, Kim B. Epilepsy management. Issues in medical and surgical treatment. Postgrad Med 1997; 102:102-104, 109-112, 115-118.
39. LaRoche SM, Helmers SL. The new antiepileptic drugs: clinical applications. JAMA 2004; 291:615-620.
40. Leppik IE, Bergey GK, Ramsay RE, et al. Advances in antiepileptic drug treatments. A rational basis for selecting drugs for older patients with epilepsy. Geriatrics 2004; 59:14-18, 22-24.
41. Garrard J, Harms S, Hardie N, et al. Antiepileptic drug use in nursing home admissions. Ann Neurol 2003; 54:75-85.
42. Lackner TE. Strategies for optimizing antiepileptic drug therapy in elderly people. Pharmacotherapy 2002; 22:329-364.
43. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62:1252-1260.
44. Sirven JI, Sperling M, Naritoku D, et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology 2000; 54:1179-1182.
45. McLachlan RS, Chovaz CJ, Blume WT, Girvin JP. Temporal lobectomy for intractable epilepsy in patients over age 45 years. Neurology 1992; 42:662-665.
46. Sirven JI, Malamut BL, O'Connor MJ, Sperling MR. Temporal lobectomy outcome in older versus younger adults. Neurology 2000; 54:2166-2170.
47. Birnbaum A, Hardie NA, Leppik IE, et al. Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology 2003; 60:555-559.
48. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use. Epilepsia 1998; 39:1083-1087.
49. Pugh MJ, Cramer J, Knoefel J, et al. Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy. J Am Geriatr Soc 2004; 52:417-422.
50. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37:81-87.
51. Alsaadi TM, Koopmans S, Apperson M, Farias S. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure 2004; 13:58-60.
52. Briggs DE, French JA. Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf 2004; 3:415-424.
53. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA 2004; 291:605-614.
54. Boggs JG, Waterhouse EJ, DeLorenzo RJ. Treatment of epilepsy in the setting of renal and liver disease. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins. In press.
55. Holt-Seitz A, Wirrell EC, Sundaram MB. Seizures in the elderly: etiology and prognosis. Can J Neurol Sci 1999; 26:110-114.
56. Hauser WA, Cascino GD, Annegers JF, Rocca WA. Incidence of status epilepticus and associated mortality [abstract]. Epilepsia 1994; 35(suppl 8):33.
57. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population- based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46:1029-1035.
58. Knake S, Rosenow F, Vescovi M, et al, Status Epilepticus Study Group Hessen (SESGH). Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42:714-718.
59. DeLorenzo RJ. Clinical and epidemiological study of status epilepticus in the elderly. In: Rowan AJ, Ramsay RE, eds. Seizures and Epilepsy in the Elderly. Newton, MA: Butterworth-Heinemann; 1997:191-205.
60. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965- 1984. Neurology 1998; 50:735-741.
61. Celesia GG, Messert B, Murphy MJ. Status epilepticus of late adult onset. Neurology 1972; 22:1047-1055.
62. Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging 2001; 18:133-142.
63. Sung CY, Chu NS. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol Scand 1989; 80:51-56.
64. Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002; 58:1070-1076.
65. Lee SI. Nonconvulsive status epilepticus-ictal confusion in later life. Arch Neurol 1985; 42:778-781.
66. Labar D, Barrera J, Solomon G, Harden C. Nonconvulsive status epilepticus in the elderly: a case series and review of the literature. J Epilepsy 1998; 11:74-78.
67. Litt B, Wityk RJ, Hertz SH, et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998; 39:1194-1202.
68. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12:316-325.
69. Delanti N, French JA, Labar DR, Pedley TA, Rowan AJ. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 2001; 10:116-119.
70. Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice parameters of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 2001; 58:1369-1374.
71. Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav 2004; 5(suppl 2):S24-S29.
72. Valimaki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on anti-epileptic drugs. J Bone Miner Res 1994; 9:631-637.
73. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002; 59:1348-1353.
74. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001; 57:445-449.
75. Andress DL, Ozuna J, Tirschwell D, et al. Antiepileptic druginduced bone loss in young male patients who have seizures. Arch Neurol 2002; 59:781-786.
76. Pack AM, Olarte L, Morrell M, Flaster E, Resor SR, Shane E. Bone mineral density in an outpatient population receiving enzymeinducing antiepileptic drugs. Epilepsy Behav 2003; 4:169-174.
77. Espallargues M, Sampietro-Colom L, Estrada MD, et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 2001; 12:811-822.
78. Richens A, Rowe DFJ. Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J 1970; 4:73-76.
79. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 1986; 59:569-577.
80. O'Hare JA, Duggan B, O'Driscoll D, Callaghan N. Biochemical evidence for osteomalacia with carbamazepine therapy. Acta Neurol Scand 1980; 62:282-286.
81. Pack AM, Morrell MJ, Randall A, Flynn KL, Done S, Flaster E. Markers of general bone function, bone formation, and bone resorption in women with epilepsy on antiepileptic drug monotherapy [abstract]. Neurology 2003; 60(suppl 1):A432.
82. Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999; 8:339-342.
83. Martin R, Vogtle L, Gilliam F, Faught E. Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research. Epilepsy Behav 2003; 4:626-634.
84. Baker GA, Jacoby A, Buck D, Brooks J, Potts P, Chadwick DW. The quality of life of older people with epilepsy: findings from a UK community study. Seizure 2001; 10:92-99